However, inhibitors of the protein–protein interaction (PPI) between the S protein and hACE2 have recently drawn increasing attention for the development of potential antiviral agents to prevent viral attachment and cellular entry to control the ongoing COVID-19 pandemic (Tai et al., 2020; Bojadzic et al., 2021). Here, PROS1 is linked to COVID-19.